Ms Sumitra Sachidanandan

Ms Sumitra Sachidanandan

Ms Sumitra is a Regulatory Consultant at the Innovation Office & Clinical Trials Branch of the Health Products Regulation Group at the Health Sciences Authority (HSA) in Singapore. She heads the GCP Compliance Inspection Unit, which is responsible for conducting GCP Inspections of clinical trials regulated by HSA and quality improvement initiatives. She is a Topic Lead representing HSA for the ICH E6 (R3) Expert Working Group of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and also a delegate representing Singapore for the Joint Sectoral Committee on ASEAN Mutual Recognition Arrangement (MRA) for Bioequivalence Study Reports of Generic Medicinal Products (JSC MRA BE). Her clinical trial experience spans over 28 years, involving monitoring, project management, academia, auditing and GCP inspections from private to public sectors.